Clinical trial · Interventional
Feasibility of a Modular mHealth for Tailored Rehabilitation of Breast Cancer
Feasibility of a Modular mHealth for Tailored Rehabilitation During the Treatment of Breast Cancer
NCT04781712CI-TRIAL-00061740MMHTRcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study investigated the feasibility of the novel modular mobile health (mHealth) for personalized rehabilitation and explored the participants' satisfaction and app data during treatment of breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Modular mHealth for Tailored Rehabilitation | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Self-management using mHealth
- description
- Self-management (physical activity, sleep, exercise, education, etc.) using mHealth
- interventionNames
- Behavioral: Modular mHealth for Tailored Rehabilitation
- type
- NO_INTERVENTION
- label
- Exercise using brochure
- description
- Only exercise using brochure
Primary outcomes (3)
- measure
- satisfaction score in app contents
- timeFrame
- 1 to 12month
- description
- satisfaction score in app contents, Likert scale (5-point, higher scores mean a better)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Unilateral breast cancer at TNM stage 0 \~ III * Patients who will undergo the treatment (chemotherapy, radiation therapy, and hormone therapy) after surgery * Patients who had a mobile phone (Android or iOS) Exclusion Criteria: \- Patients who have metastases or recurrence to other organs were excluded
References
Publications (0)
Data not yet available
No reference posted for this study.